Skip to main content

Advertisement

Log in

Terminal deoxynucleotidyl transferase in human lymphomas: possible existence of forms with high and low molecular weights

  • Original Article
  • Published:
British Journal of Cancer Submit manuscript

Abstract

Optimized methods for extraction and enzyme assay in crude tissue preparations were used to determine the amounts of terminal deoxnucleotidyl transferase (TdT) in malignant lymphomas. The TdT concentration was increased only in lymphoblastic lymphomas (LL) and was as high in these tumours as in the white blood cells from untreated patients with acute lymphoblastic leukaemia (ALL). The enzymes extracted from such lymphomas and from the leukaemic lymphoblasts had the same properties. Moreover, forms of TdT with low and high mol. wt were found in the LL tumours, similar to other reports of TdT-positive leukaemias. The overall study points at some basic biochemical identity of certain lymphoblastic malignancies, irrespective of whether the transformed cells are in solid tumours or are disseminated in the blood.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vezzoni, P., Campagnari, F., Di Fronzo, G. et al. Terminal deoxynucleotidyl transferase in human lymphomas: possible existence of forms with high and low molecular weights. Br J Cancer 43, 312–319 (1981). https://doi.org/10.1038/bjc.1981.49

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/bjc.1981.49

  • Springer Nature Limited

Navigation